Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16415850 | 1.00 | TSHR (0.30) | TSHRCYP2C19 | |
| SCHEMBL9792256 | 1.00 | TSHR (0.30) | TSHRCYP2C19 | |
| SCHEMBL2986913 | 1.00 | TSHR (0.30) | TSHRCYP2C19 | |
| SCHEMBL2395690 | 0.96 | — | — | |
| SCHEMBL4412549 | 0.96 | — | — | |
| SCHEMBL30615700 | 0.96 | TSHR (0.35) | TSHRCYP2C19 | |
| SCHEMBL31139018 | 0.96 | TSHR (0.35) | TSHRCYP2C19 | |
| SCHEMBL4415844 | 0.96 | — | — | |
| SCHEMBL11145456 | 0.96 | TSHR (0.35) | TSHRCYP2C19 | |
| SCHEMBL10597160 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220185836-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS | XLINK THERAPEUTICS INC (US) | 2022-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220185836-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS | TP53, VHL, KRAS | TSHR 3883/4885CYP2C19 2838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.